K.Venkateshwar.Rao

SOCIETY   / K. Venkateshwar Rao 9 APRIL 2020 American President Donald Trump is so fascinated by the healing capabilities of the Indian anti-malaria drug hydroxychloroquine that he has forgotten his bonhomie with the Indian Prime Minister Narendra Modi and gone to the extent of threatening retaliatory actions if India does not permit exports of the drug to America. Hydroxychloroquine Has Shown Some Positive Results in Treating Covid-19 Hydroxychloroquine has been successfully used by some doctors in the treatment of coronavirus and has been termed as a game-changer by Trump in the fight against coronavirus. Hydroxychloroquine is popularly known as an antiviral agent has displayed strong antiviral effects on the coronavirus infection and is currently being experimented by many countries as a possible treatment for SARS-CoV-2 that causes Covid-19. China found that chloroquine could slow down SARS-CoV-2 in vitro, and indicated apparent efficacy in treating COVID-19 in hu...

POLITICS   / K. Venkateshwar Rao 31 JANUARY 2020 Contrary to the promise of a “bigger and better deal,” the proposed Middle East Israeli-Palestinian peace plan by US President Donald Trump appears to be an exercise meant to benefit him and Israeli Prime Minister Benjamin Netanyahu in the electoral battle. The p,an is likely to create problems rather than solve them and is mainly meant to bolster the fortunes of Trump and Netanyahu in the US and Israeli elections, respectively. Taking a sharp departure from decades of the American policy that advocates the creation of a Palestinian state with slight adjustments to the Israeli boundaries that existed before the Arab-Israeli war of 1967, Trump’s Plan recognizes and legitimizes the Jewish settlements built on occupied Palestinian territory, which are regarded as illegal under international law. The Plan Threatens The Two-State Solution Trump’s plan is not only a threat to the idea of creation of a Palestinian state with its...

ECONOMY   / K. Venkateshwar Rao 17 JANUARY 2020 A year after expressing his inability to attend the Republic Day parade in the Indian capital, the US President Donald Trump will be visiting India in February to sign a short term trade deal, paving the way for a longer-term agreement on a later date. Officials from New Delhi and Washington are working out mutually convenient times for the US President Donald Trump’s visit to India. According to trade observers, Trump wants to counterbalance China with India, which has a considerable market and offers high potentials for US investors. The US, which is a prominent supplier of arms to India, is keen to have greater access to the vast Indian consumer market. The trade agreement with India will be an essential achievement of the Trump administration with the US President seeking a second term in November. With the Modi government, struggling with a slowing Indian economy and keen to attract investment to revive it, a trade pa...